ABVC BioPharma Inc (ABVC)
0.7686
+0.03
(+4.30%)
USD |
NASDAQ |
Jun 28, 16:00
0.7686
0.00 (0.00%)
After-Hours: 16:45
ABVC BioPharma Research and Development Expense (TTM): 0.797M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.797M |
| December 31, 2023 | 1.063M |
| September 30, 2023 | 2.486M |
| June 30, 2023 | 2.651M |
| March 31, 2023 | 2.669M |
| December 31, 2022 | 2.694M |
| September 30, 2022 | 1.458M |
| June 30, 2022 | 1.416M |
| March 31, 2022 | 1.242M |
| December 31, 2021 | 1.004M |
| September 30, 2021 | 0.9269M |
| June 30, 2021 | 0.798M |
| March 31, 2021 | 0.5782M |
| December 31, 2020 | 0.5497M |
| September 30, 2020 | 0.636M |
| June 30, 2020 | 0.7707M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7194M |
| December 31, 2019 | 1.049M |
| September 30, 2019 | 1.089M |
| June 30, 2019 | 0.8746M |
| March 31, 2019 | 0.8435M |
| December 31, 2018 | 0.6697M |
| September 30, 2018 | 0.405M |
| June 30, 2018 | 3.434M |
| March 31, 2018 | 3.395M |
| December 31, 2017 | 3.172M |
| September 30, 2017 | 3.151M |
| June 30, 2017 | 0.0678M |
| March 31, 2017 | 0.0503M |
| December 31, 2016 | 6.525M |
| September 30, 2016 | 10.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.5497M
Minimum
Dec 2020
2.694M
Maximum
Dec 2022
1.274M
Average
1.026M
Median
Research and Development Expense (TTM) Benchmarks
| Sutro Biopharma Inc | 197.90M |
| Reviva Pharmaceuticals Holdings Inc | 31.97M |
| Flora Growth Corp | 0.093M |
| Journey Medical Corp | 13.39M |
| NovaBay Pharmaceuticals Inc | 0.061M |